; and (B) not later than March 15 of each year following the year in which the first list of critical medications is required by paragraph (1)— (i) update the list required by paragraph (1); (ii) submit an updated report under subparagraph (A)(ii); and (iii) make publicly available such updated list and report in accordance with subparagraph (A)(iii). (4) Required inclusion on list Subject to paragraph (5), the Secretary shall include on the list under paragraph (1) the following medications: (A) Commonly-used medications likely to be needed in order to prevent, mitigate, or treat the adverse health effects which frequently result from a public health emergency, including medications routinely needed to effectively manage patients in hospital emergency rooms or intensive care units, and medications needed during surgical procedures often required during a public health emergency. (B) Anti-infective medications, including antibiotic, antifungal, and antiviral medications, which are either commonly used to treat infectious diseases or have a significant likelihood of being needed to treat an infectious disease that, if not so treated, may result in a public health emergency. (C) Commonly-used medications which are life-supporting, life-sustaining, or intended for the use in the prevention or treatment of a debilitating disease or condition, as such terms are defined in section 506C of the Federal Food, Drug, and Cosmetics Act and the regulations thereunder. (5) Limitations on inclusion on list The Secretary— (A) shall not be required to include on the list under paragraph (1) every medication meeting the criteria described in paragraph (4); (B) shall prioritize the inclusion on the list under paragraph (1) of 300 to 400 medications meeting such criteria— (i) that are most commonly used; or (ii) for which a shortage would be most likely to have the greatest potential adverse health consequences